Projects per year
Response to Letter Regarding Article, "Targeting Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Based on Risk of Intracranial Hemorrhage or Poor Functional Outcome: An Analysis of the Third International Stroke Trial"
William N. Whiteley*, Douglas Thompson, Peter Sandercock
*Corresponding author for this work
Research output: Contribution to journal › Letter